Skip to main content

Resources for healthcare providers

Find resources to support your gastroparesis patients and practice.

Clinical resources

Find clinical resources to support your gastroparesis patients and practice.

Patient education

Explore resources to support your patients’ journey in considering, preparing for, and living with Enterra® Therapy.

Media kit

Find public relations and marketing assets for Enterra® Therapy.

Manual library

Instructions for use and product manuals for healthcare professionals.

Grants & Investigator Sponsored Research (ISR) Program

Enterra Medical is dedicated to supporting educational and scientific advancements through the support of the grants or ISR support program.

MKT-D-0006, Rev M


Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.


Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?